MaxCyte, Inc.

📍 Rockville, United States🗓 Founded 1999👥 143 employees💰 Last funded Oct 2024
Biotechnology🌐 maxcyte.com
Website LinkedIn
We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERT™ platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in MaxCyte, Inc.?
MaxCyte, Inc. has 2 investors on record on gritt.io.
When did MaxCyte, Inc. last raise funding?
The most recent investment in MaxCyte, Inc. recorded on gritt.io was in October 2024.
When was MaxCyte, Inc. founded?
MaxCyte, Inc. was founded in 1999.
What industry is MaxCyte, Inc. in?
MaxCyte, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is MaxCyte, Inc. based?
MaxCyte, Inc. is headquartered in Rockville, United States.